DermaSensor Inc.

DermaSensor Inc. is a health technology company that has developed the first FDA-cleared, AI-powered medical device for the non-invasive detection of the three most common skin cancers: melanoma, basal cell carcinoma, and squamous cell carcinoma. The handheld device utilizes Elastic Scattering Spectroscopy (ESS) and proprietary machine learning algorithms to analyze skin lesions at cellular and subcellular levels, providing immediate, objective results at the point of care. Headquartered in Miami, Florida, the company focuses on empowering primary care physicians (PCPs) to better evaluate suspicious skin lesions, addressing a significant gap in dermatology access. By providing a 'point and click' diagnostic tool, DermaSensor aims to improve early detection rates and optimize the referral process to specialists, potentially saving lives through earlier intervention in skin cancer cases.